Comvac 1g IV

 

 

• A Glycopeptide antibiotic, first line agent in the treatment of penicillinase-producing strains.
• Most reliable therapeutic agent against infections caused by MRSA.
• Intrathecal administration of Comvac (vancomycin) is very effective & safe treatment for MRSA* meningitis.
• Comvac (vancomycin) has been used successfully in combination with either rifampin, an aminoglycoside, or both in early-onset prosthetic value endocarditis caused by S. epidermidis or diphtheroids

. • Comvac (vancomycin) inhibits bacterial cell wall synthesis and is bactericidal during cell division at therapeutic concentrations. -411

 

INDICATIONS:

• Acute Leukaemia
• Bacteremia
• Brain Abscesses
• Chronic Myeloid Leukaemia
• Colitis
• Constipation & Bowel Evacuation
• Endocarditis
• Meningitis, Peritonitis

 

 

DOSAGE & ADMINISTRATION:

–

 

• New Born Babies (0-7 days old) :

Starting dose of 15 mg for each kg of child’s wt, followed by 10 mg/kg every 12 hours.

• New Born Babies (7-30 days old) :

Starting dose of 15 mg for each kg of child’s wt, followed by 10 mg/kg every 8 hours.

• Children (1 month to 12 years of age) :

Usual IV dosage is 10 mg/kg/dose every 6 hours (total daily dosage 40 mg/kg of body weight)

• Adult & Children N 12 years) :

2 g daily in 2-4 doses (or 30 mg/kg/body weight/day or 500 mg every 6 hours or 1 g every 12 hours)

MRP Rs. 1382/: